During the Special Symposium at ESMO 2019 “Stratified treatment in metastatic colorectal cancer” on 29 September, COLOSSUS PI Dr Rodrigo Dienstmann of Vall d’Hebron Institute of Oncology presented COLOSSUS in his talk entitled “New molecular stratification of colorectal cancer”. New molecular stratification of colorectal cancer will involve functional subtypes that reflect cancer cell and microenvironment dependencies that can be targeted for new treatments. COLOSSUS will identify functional MSS RAS mutated subtypes.
ESMO, the European Society for Medical Oncology is Europe’s leading medical oncology society, providing a professional network for its members and working with national societies across Europe. ESMO has more than 23,000 members representing oncology professionals from over 150 countries worldwide. The ESMO Congress 2019 took place in Barcelona from September 27th to October 1st.